DR LAL PATHLABS
Back to Income Statement
|
DR LAL PATHLABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹358 Cr | ₹239 Cr | ₹345 Cr | ₹292 Cr | ₹226 Cr |
What is the latest Consolidated Net Profit of DR LAL PATHLABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹358 Cr |
| Mar2024 | ₹239 Cr |
| Mar2023 | ₹345 Cr |
| Mar2022 | ₹292 Cr |
| Mar2021 | ₹226 Cr |
How is Consolidated Net Profit of DR LAL PATHLABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹358 Cr | 49.78 | |
| Mar2024 | ₹239 Cr | -30.74 | |
| Mar2023 | ₹345 Cr | 18.25 | |
| Mar2022 | ₹292 Cr | 29.07 | |
| Mar2021 | ₹226 Cr | - | |
Compare Consolidated Net Profit of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹26,328.7 Cr | -0.5% | 0.1% | 5.3% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹114,822.0 Cr | 5.3% | -1.8% | 16.7% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹106,299.0 Cr | -1.3% | -7.7% | 10.1% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹69,535.4 Cr | -2.5% | -16.1% | 44% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹41,743.8 Cr | 0.7% | 14.8% | 60.5% | Stock Analytics | |
| GLOBAL HEALTH | ₹32,963.1 Cr | 1.8% | -11.9% | 12.3% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | -0.5% |
0.1% |
5.3% |
| SENSEX | 0.8% |
1% |
9.9% |
You may also like the below Video Courses